137 related articles for article (PubMed ID: 38122932)
21.
Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
[TBL] [Abstract][Full Text] [Related]
22. Strategy of operative treatment of hyperparathyroidism using US scan and (99m)Tc-MIBI SPECT/CT.
Noda S; Onoda N; Kashiwagi S; Kawajiri H; Takashima T; Ishikawa T; Yoshida A; Higashiyama S; Kawabe J; Imanishi Y; Tahara H; Inaba M; Osawa M; Hirakawa K
Endocr J; 2014; 61(3):225-30. PubMed ID: 24335008
[TBL] [Abstract][Full Text] [Related]
23. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
[TBL] [Abstract][Full Text] [Related]
24. Incremental value of 99m Tc-MIBI single-photon emission computed tomography/computed tomography fusion imaging for the diagnosis of secondary hyperparathyroidism.
Peng Y; Pan G; Zhao B; Zuo C; Wang Y; Chen R
Nucl Med Commun; 2023 Sep; 44(9):767-771. PubMed ID: 37395545
[TBL] [Abstract][Full Text] [Related]
25. Impact of Fluoro-Choline PET/CT in Reduction in Failed Parathyroid Localization in Primary Hyperparathyroidism.
Aphale R; Damle N; Chumber S; Khan M; Khadgawat R; Dharmashaktu Y; Agarwal S; Bal C
World J Surg; 2023 May; 47(5):1231-1237. PubMed ID: 36599952
[TBL] [Abstract][Full Text] [Related]
26. PETC/CT with
Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hyperplasia detected by F-18-Choline PET/CT, negative on Tc-99m-MIBI SPECT/CT and F-18-Deoxyglucose PET/CT scans.
Nocuń A; Kędra M; Stefaniak B; Chrapko B
Nucl Med Rev Cent East Eur; 2017; 20(1):60-61. PubMed ID: 28218350
[No Abstract] [Full Text] [Related]
28. 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas.
Noltes ME; Rotstein L; Eskander A; Kluijfhout WP; Bongers P; Brouwers AH; Kruijff S; Metser U; Pasternak JD; Veit-Haibach P
Langenbecks Arch Surg; 2023 Apr; 408(1):155. PubMed ID: 37079138
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
Thanseer N; Bhadada SK; Sood A; Mittal BR; Behera A; Gorla AKR; Kalathoorakathu RR; Singh P; Dahiya D; Saikia UN; Rao SD
Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Localization of Adenomas in Primary Hyperparathyroidism: The Value of
Liu Y; Dang Y; Huo L; Hu Y; Wang O; Liu H; Chang X; Liu Y; Xing X; Li F; Liao Q; Hacker M; Li X; Kreissl MC
J Nucl Med; 2020 Apr; 61(4):584-589. PubMed ID: 31601698
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of clinical parameters and parathyroid scintigraphy for asymptomatic primary hyperparathyroidism.
Ning Y; Chen D; Huang Z; Lou C
Hell J Nucl Med; 2020; 23(2):148-157. PubMed ID: 32716406
[TBL] [Abstract][Full Text] [Related]
32. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
Quak E; Lasne Cardon A; Ciappuccini R; Lasnon C; Bastit V; Le Henaff V; Lireux B; Foucras G; Jaudet C; Berchi C; Grellard JM; Lequesne J; Clarisse B; Bardet S
BMC Endocr Disord; 2021 Jan; 21(1):3. PubMed ID: 33413316
[TBL] [Abstract][Full Text] [Related]
33. Four-dimensional computed tomography (4D-CT) for preoperative parathyroid localization: A good study but are we using it?
Kuo LE; Bird SH; Lubitz CC; Pandian TK; Parangi S; Stephen AE
Am J Surg; 2022 Apr; 223(4):694-698. PubMed ID: 34579935
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of ultrasonography and Tc-99m MIBI SPECT/CT in preoperative localization of parathyroid adenomas causing primary hyperthyroidism.
Lu R; Zhao W; Yin L; Guo R; Wei B; Jin M; Zhou X; Zhang C; Lv X
BMC Med Imaging; 2021 May; 21(1):87. PubMed ID: 34020602
[TBL] [Abstract][Full Text] [Related]
35.
Zeng M; Liu W; Zha X; Tang S; Liu J; Yang G; Mao H; Yu X; Sun B; Zhang B; Ouyang C; Zhang L; Guo J; Wang J; Huang Y; Purrunsing Y; Qian H; Wang N; Xing C
Ren Fail; 2019 Nov; 41(1):885-892. PubMed ID: 31537128
[No Abstract] [Full Text] [Related]
36. Virtual neck exploration in patients with hyperparathyroidism and former cervical operations.
Wimmer G; Bale R; Kovacs P; Gabriel M; Putzer D; Sauper T; Sieb M; Profanter C; Margreiter R; Prommegger R
Langenbecks Arch Surg; 2008 Sep; 393(5):687-92. PubMed ID: 18575883
[TBL] [Abstract][Full Text] [Related]
37. Can we skip technetium-99 m sestamibi scintigraphy in pediatric primary hyperparathyroidism patients with positive neck ultrasound results?
He Y; Luo Y; Jin S; Wang O; Liao Q; Zhu Q; Liu H
Pediatr Radiol; 2023 Oct; 53(11):2253-2259. PubMed ID: 37438472
[TBL] [Abstract][Full Text] [Related]
38.
Gauthé M; Dierick-Gallet A; Delbot T; Bricaire L; Bertherat J; North MO; Cochand-Priollet B; Bouchard P; Talbot JN; Groussin L; Gaujoux S
World J Surg; 2020 Nov; 44(11):3761-3769. PubMed ID: 32681321
[TBL] [Abstract][Full Text] [Related]
39. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
Quak E; Blanchard D; Houdu B; Le Roux Y; Ciappuccini R; Lireux B; de Raucourt D; Grellard JM; Licaj I; Bardet S; Reznik Y; Clarisse B; Aide N
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):658-666. PubMed ID: 29270788
[TBL] [Abstract][Full Text] [Related]
40. 18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.
Talbot JN; Périé S; Tassart M; Delbot T; Aveline C; Zhang-Yin J; Kerrou K; Gaujoux S; Wagner I; Bennis M; Ménégaux F; Breton S; Cochand-Priollet B; Christin-Maitre S; Groussin L; Haymann JP; Baujat B; Balogova S; Montravers F
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):96-113. PubMed ID: 36995286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
